Capital International Investors’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $526M | Buy |
3,046,931
+172,139
| +6% | +$29.7M | 0.09% | 161 |
|
|
2025
Q1 | $448M | Buy |
2,874,792
+11,543
| +0.4% | +$1.8M | 0.09% | 167 |
|
|
2024
Q4 | $394M | Buy |
2,863,249
+753,859
| +36% | +$104M | 0.07% | 177 |
|
|
2024
Q3 | $315M | Buy |
2,109,390
+5,092
| +0.2% | +$760K | 0.06% | 195 |
|
|
2024
Q2 | $287M | Sell |
2,104,298
-87,014
| -4% | -$11.9M | 0.06% | 193 |
|
|
2024
Q1 | $331M | Buy |
2,191,312
+10,044
| +0.5% | +$1.52M | 0.07% | 197 |
|
|
2023
Q4 | $275M | Buy |
2,181,268
+12,825
| +0.6% | +$1.62M | 0.06% | 201 |
|
|
2023
Q3 | $203M | Buy |
2,168,443
+173,172
| +9% | +$16.2M | 0.05% | 215 |
|
|
2023
Q2 | $178M | Buy |
1,995,271
+6,165
| +0.3% | +$550K | 0.04% | 243 |
|
|
2023
Q1 | $213M | Buy |
1,989,106
+421,109
| +27% | +$45.2M | 0.05% | 225 |
|
|
2022
Q4 | $191M | Buy |
1,567,997
+248,546
| +19% | +$30.4M | 0.05% | 244 |
|
|
2022
Q3 | $136M | Buy |
1,319,451
+12,430
| +1% | +$1.28M | 0.04% | 266 |
|
|
2022
Q2 | $122M | Buy |
1,307,021
+1,060,819
| +431% | +$98.6M | 0.03% | 283 |
|
|
2022
Q1 | $28.9M | Buy |
+246,202
| New | +$28.9M | 0.01% | 386 |
|